BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 2000
View Archived Issues
Wilex updates product pipeline, focusing on forward integration
Read More
Centaur's treatment for AIDS dementia making steady progress in phase II
Read More
Synergistic anti-HBV combinations under study at Glaxo Wellcome
Read More
Novel growth factor from the GDNF family discovered by U.S. academics
Read More
PEG-Intron at least as effective and safe as Intron A in phase III HCV trial
Read More
AastromRepliCell System offers hope for CML patients
Read More
Altropane shows high accuracy, sensitivity and specificity as diagnostic for early PD
Read More
Abbott's extended-release Biaxin XL now available in U.S.
Read More
Integrin antagonists disclosed by BioChem Pharma for inhibiting angiogenesis and tumor growth
Read More
Japanese lab presents novel agents for AD and other neurodegenerative diseases
Read More
New antimigraine agents in early development at NPS with selectivity for 5-HT1D receptor
Read More
SCRAS presents another group of dual NOS inhibitors/antioxidants
Read More
Several patents issued to Pfizer covering CETP inhibitors and their use
Read More
Merck's new CGRP ligands particularly useful in migraine Rx
Read More
Global CORAL study will evaluate oral Copaxone in relapsing-remitting MS
Read More
SB researchers publish synthesis of new PDE4 inhibitor
Read More
Licensing opportunity from NIH: HIV-1 integrase inhibitors
Read More
Microbial metabolite Sch-351448 acts as a selective LDL receptor promoter activator
Read More
Licensing opportunity from NIH: MAb for the treatment, diagnosis of prostate cancer
Read More
New Canadian venture formed for the development of heart disease and stroke therapies
Read More
Licensing opportunity from NIH: antibodies and immunotoxins for treating, diagnosing cancer
Read More
ADL-2-1294 licensed to Santen for ophthalmic indications
Read More
Dapsone topical gel progresses through the pipeline for acne and itch
Read More
FDA grants expedited review to first PCR-based tests for HCV
Read More
Structure and cardioprotective effects of RC-552 reported at Experimental Biology 2000
Read More
Antisense oligodeoxynucleotides with potential in hypertension and myocardial hypertrophy
Read More
ITB Therapy copromotion alliance expanded by Cephalon and Medtronic
Read More
